A Multicenter, Prospective, Noninterventional Study in a Norwegian Cohort of Patients with Moderate-to-Severe Allergic Rhinitis Treated with MP-AzeFlu
Background Allergic Rhinitis and its Impact on Asthma guidelines recently recommended a treatment strategy for allergic rhinitis (AR) based on disease control rather than symptom severity by using a visual analog scale (VAS) to categorize control Objectives To evaluate the effectiveness of MP-AzeFlu...
Main Authors: | Ralph Dollner Ph.D., Petter Lorentz Larsen M.D., Sinan Dheyauldeen M.D., Sverre Steinsvåg M.D. |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2017-10-01
|
Series: | Allergy & Rhinology |
Online Access: | https://doi.org/10.2500/ar.2017.8.0216 |
Similar Items
-
MP-AzeFlu Improves the Quality-of-Life of Patients with Allergic Rhinitis
by: van Weissenbruch R, et al.
Published: (2020-12-01) -
Allergic rhinitis and asthma symptoms in a real-life study of MP-AzeFlu to treat multimorbid allergic rhinitis and asthma
by: David Price, et al.
Published: (2020-08-01) -
Evaluating the real-life effect of MP-AzeFlu on asthma outcomes in patients with allergic rhinitis and asthma in UK primary care
by: Hilda J.I. De Jong, et al.
Published: (2020-12-01) -
Effects of MP-AzeFlu enhanced by activation of bitter taste receptor TAS2R
by: Sandra Ekstedt, et al.
Published: (2020-06-01) -
Superior effect of MP-AzeFlu than azelastine or fluticasone propionate alone on reducing inflammatory markers
by: Jordi Roca-Ferrer, et al.
Published: (2018-12-01)